Groupe la Francaise’s AbbVie ABBV Stock Holding History

Groupe la Francaise’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.5M	Buy	303,838 +110,458	+57%	+$23.8M	0.92%	25
2026 Q1	$42.1M	Buy	193,380 +73,045	+61%	+$16.2M	0.58%	39
2025 Q4	$27.5M	Buy	120,335 +93,289	+345%	+$21.3M	0.39%	51
2025 Q3	$6.16M	Buy	27,046 +1,670	+7%	+$340K	0.08%	139
2025 Q2	$4.69M	Buy	25,376 +6,466	+34%	+$1.2M	0.08%	155
2025 Q1	$3.83M	Buy	18,910 +2,344	+14%	+$456K	0.08%	160
2024 Q4	$2.93M	Buy	+16,566	New	+$3.05M	0.07%	157

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Groupe la Francaise's ABBV Position: Q2 2026 in Review

Groupe la Francaise increased its AbbVie (ABBV) stake by 57% in Q2 2026, buying an estimated $23.8M and bringing the position to 303,838 shares worth $76.5M. The position accounts for 0.92% of the portfolio, ranked #25.

Groupe la Francaise first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Groupe la Francaise held 303,838 shares of AbbVie worth $76.5M as of Q2 2026.
Groupe la Francaise bought 110,458 AbbVie shares in Q2 2026, an estimated $23.8M.
AbbVie made up 0.92% of Groupe la Francaise's portfolio in Q2 2026, its #25 holding.
Groupe la Francaise first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.